Skip to main navigation Skip to search Skip to main content

3D printing the future: sustainable solutions in pharmaceutical manufacturing

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The pharmaceutical industry faces growing pressure to adopt more sustainable manufacturing practices due to increasing environmental concerns and stringent regulatory demands. Traditional manufacturing processes are often resource-intensive, generating significant waste, consuming large amounts of energy, and contributing to a substantial carbon footprint. As the industry looks for innovative solutions to address these challenges, additive manufacturing, particularly three-dimensional (3D) printing, has emerged as a promising alternative. This chapter explores the transformative potential of 3D printing in achieving sustainability within pharmaceutical manufacturing. It examines how 3D printing can reduce material waste, enhance energy efficiency, and enable localized, on-demand production. Key applications in pharmaceuticals, such as personalized medicine, drug delivery systems, and rapid prototyping, are discussed in depth. The chapter also addresses the regulatory landscape, highlighting both challenges and opportunities for adopting 3D printing technologies. Through case studies, the real-world impact of 3D printing on reducing environmental burdens is explored, along with future trends in sustainable pharmaceutical manufacturing.

Original languageEnglish
Title of host publicationSustainability in the Manufacturing of Pharmaceuticals
PublisherElsevier GmbH
Pages121-153
Number of pages33
ISBN (Electronic)9780443289217
ISBN (Print)9780443289224
DOIs
Publication statusPublished - 1 Jan 2025

Keywords

  • Additive manufacturing of medicinal drug products
  • energy efficiency in pharma
  • green manufacturing
  • personalised medicines
  • pharmaceutical supply chain sustainability
  • sustainable medication production

Fingerprint

Dive into the research topics of '3D printing the future: sustainable solutions in pharmaceutical manufacturing'. Together they form a unique fingerprint.

Cite this